Cannabis finance news

Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics

by Martin Lane October 3, 2023April 30, 2024

ASX-listed Bioxyne has released its first annual report since it acquired Breathe Life Sciences (BLS) in […]

ECS Botanics and MediCann Health strike A$24m offtake deal

by Martin Lane October 3, 2023April 30, 2024

Ben Jansen launches new bid to rejoin Vitura Health board

by Steve Jones October 3, 2023April 30, 2024

Company news: Vantage Hemp; Neurotech International; MediPharm Labs/Beacon Medical; Cann Group

by Martin Lane September 28, 2023April 30, 2024

Roby Zomer

MGC Pharma flags restructure in face of ‘dire alternatives’

by Martin Lane September 26, 2023September 28, 2023

Cann Global applies to extend trading halt again as it pursues ‘major’ acquisition opportunity

by Martin Lane September 18, 2023April 30, 2024

Cannabis executive salaries: who earned what in FY23

by Steve Jones September 13, 2023September 14, 2023

Emyria completes acquisition of Pax Centre for A$1.7m

by Martin Lane September 13, 2023April 30, 2024

Medlab updates shareholders on ‘proposed restructure’

by Martin Lane September 12, 2023April 30, 2024

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

by Martin Lane and Steve Jones September 4, 2023April 30, 2024